Epizyme's Rhodes resigns as president, CFO

Cancer epigenetics company Epizyme Inc. (NASDAQ:EPZM) said Jason Rhodes resigned as president and CFO, effective Sept. 30. The company said Rhodes is joining an undisclosed VC fund. Prior to joining Epizyme in 2010, Rhodes was VP of business development at Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY). ...